Stem Cell Treatment for Diabetes
Insulin is a very important hormone that is produced by the pancreas and helps to keep the body’s blood sugar (glucose) levels in check. Diabetes is caused when there is an imbalance of insulin in the body. Type 1 Diabetes: This is usually diagnosed during childhood where the body makes very little or no insulin. In conventional therapy, there is only a way to maintain the right levels of insulin with daily injections. Type 2 Diabetes: In this condition, the body becomes resistive to insulin and the pancreas lose the capability to make enough insulin which is required to keep blood glucose levels normal. This is usually because of incorrect diet, lack or exercise or being overweight. Most diabetics suffer from Type 2 Diabetes.
Stem Cell Treatment can be used for both, Type 1 and Type 2 Diabetes.
- The long-term goals of are to:
- Prolong life
- Reduce symptoms
- Prevent diabetes-related complications such as blindness, heart disease, kidney failure and amputation of limbs
- Bring blood glucose levels under control with oral hypoglycemics
Related Conference of Stem Cell Treatment for Diabetes
19th International Conference on Human Genomics and Genomic Medicine
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
17th International Conference on Human Genetics and Genetic Diseases
Stem Cell Treatment for Diabetes Conference Speakers
Recommended Sessions
- Advances in Stem Cell
- Applications of Tissue Engineering and Regenerative Medicine
- Biochips and Tissue Chips
- Biomarkers
- Biomaterials and Bioengineering
- Bioreactors in Tissue Engineering
- Bone and Cartilage Tissue Engineering
- Cancer Stem Cells
- Chemotherapy
- Clinical Medicine
- Clinical Trials with Stem Cells
- Cord Blood Stem Cells and Regenerative Medicine
- Immunotherapy
- Materials and Designs for Tissue Engineering
- Novel Approaches in Guided Tissue Regeneration
- Regeneration and Therapeutics
- Rejuvenation
- Scaffolds
- Stem Cell Engineering (SCE)
- Stem Cell Treatment for Diabetes
- Stem Cells-Tools to Battle Cancer
- Tissue Engineering and 3D Printing
- Tissue Regeneration
- Whole Organ Engineering and Approaches
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)
